JMP Securities Initiates Coverage On Inhibrx Biosciences with Market Perform Rating
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has initiated coverage on Inhibrx Biosciences (NASDAQ:INBX) with a Market Perform rating, as per analyst Reni Benjamin.
July 23, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JMP Securities has initiated coverage on Inhibrx Biosciences with a Market Perform rating, indicating a neutral stance on the stock.
The Market Perform rating suggests that the analyst expects the stock to perform in line with the market. This neutral stance is unlikely to cause significant short-term price movements.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100